Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010.

Dʼsouza G, Matson PA, Grady CD, Nahvi S, Merenstein D, Weber KM, Greenblatt R, Burian P, Wilson TE.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):618-26. doi: 10.1097/QAI.0b013e318273ab3a.

2.

Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).

Kuo WH, Wilson TE, Weber KM, Madhava V, Richardson J, Delapenha R, Des Jarlais D.

AIDS Patient Care STDS. 2004 Dec;18(12):702-13.

PMID:
15659881
3.

Medicinal and recreational marijuana use by patients infected with HIV.

Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R.

AIDS Patient Care STDS. 2004 Apr;18(4):215-28.

PMID:
15142352
4.

High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.

Slawson G, Milloy MJ, Balneaves L, Simo A, Guillemi S, Hogg R, Montaner J, Wood E, Kerr T.

AIDS Behav. 2015 Jan;19(1):120-7. doi: 10.1007/s10461-014-0847-3.

5.

Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.

Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L.

AIDS Patient Care STDS. 2014 Mar;28(3):136-43. doi: 10.1089/apc.2013.0329. Epub 2014 Feb 25.

6.

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R, Cohen MH.

Clin Infect Dis. 2007 Jan 15;44(2):287-94. Epub 2006 Dec 12.

PMID:
17173233
7.

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.

Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, Hershow RC.

AIDS Patient Care STDS. 2009 Dec;23(12):1009-16. doi: 10.1089/apc.2009.0175.

8.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
9.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
10.

Experience of pain among women with advanced HIV disease.

Richardson JL, Heikes B, Karim R, Weber K, Anastos K, Young M.

AIDS Patient Care STDS. 2009 Jul;23(7):503-11. doi: 10.1089/apc.2008.0128.

11.

Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study.

Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen MH.

Am J Prev Med. 2014 Jul;47(1):53-69. doi: 10.1016/j.amepre.2014.02.010. Epub 2014 Apr 18.

12.

Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552.

PMID:
18176324
13.

Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.

Telzak EE, Hershow R, Kalish LA, Hardy WD Jr, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):513-8.

PMID:
9859966
14.

Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.

Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA.

J Behav Med. 2014 Feb;37(1):1-10. doi: 10.1007/s10865-012-9458-5. Epub 2012 Oct 7.

15.

Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.

Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM.

Clin Infect Dis. 2011 May;52(10):1267-75. doi: 10.1093/cid/cir131.

16.

Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea.

de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):43-6.

PMID:
15608523
17.

Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy.

Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, Carson VL, Sinclair B, Racenstein JM, Reed RA, Levine AM.

J Int Neuropsychol Soc. 2002 Sep;8(6):781-93. Erratum in: J Int Neuropsychol Soc. 2005 Jan;11(1):120.

PMID:
12240742
18.

Marijuana as therapy for people living with HIV/AIDS: social and health aspects.

Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S.

AIDS Care. 2007 Feb;19(2):295-301.

PMID:
17364413
19.

An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.

Merenstein D, Wang C, Gandhi M, Robison E, Levine AM, Schwartz RM, Weber KM, Liu C.

Complement Ther Med. 2012 Aug;20(4):222-7. doi: 10.1016/j.ctim.2012.03.001. Epub 2012 Apr 8.

20.

Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.

Shet A, Kumarasamy N, Poongulali S, Shastri S, Kumar DS, Rewari BB, Arumugam K, Antony J, De Costa A, D'Souza G.

Curr HIV Res. 2016;14(1):71-9.

PMID:
26303008

Supplemental Content

Support Center